Noel de Miranda

Affiliation: Leiden University Medical Center, NL

Keywords: Cancer, Genomics, Immunology, Immunotherapy

Webpage

ID_symbol_B-W_128x1280000-0001-6122-1024

Full profile:

Noel is a cancer biologist with a long passion for the study of the evolutionary processes that occur in cancer. He obtained his PhD at Leiden University (NL) on tumour immunology and, later, was a postdoctoral fellow at the Karolinska Institutet (SE) where he specialized in cancer genomics. Since 2015, he is the Principal Investigator of the Cancer Immunogenomics research group at the department of Pathology of the LUMC. His group develops work on several aspects on cancer immunology and genomics with a particular focus on colorectal and pancreatic cancers. The group’s translational aims are to: 1) identify cancer-specific antigens that can be targeted by immunotherapy and 2) elucidate the potential of immune cell subsets other than T cells for immunotherapeutic exploitation. These aims are accompanied by a strong curiosity in understanding and mapping out the complex and multicellular nature of anti-cancer immune responses.

Noel holds an ERC Starting Grant and was a previously awarded the Bas Mulder Young Investigator Award by the Dutch Cancer Society and a VENI award by the Dutch Organization for Scientific Research.

Noel has for years been engaged in the representation of young academics: he was a board member of the Young Faculty Network of the Leiden University Medical Center and is a current member of the Young Academy Leiden.